SCHEMBL7945984

SCHEMBL7945984

COCCn1c(=O)c(-c2cccc(C)c2)nc2c(N)ccnc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 19/20 0.51
ALDH1A1 P00352 15/20 0.51
CYP3A4 P08684 15/20 0.51
HSD17B10 Q99714 12/20 0.51
CASP1 P29466 10/20 0.51
CYP2C19 P33261 8/20 0.51
GLA P06280 3/20 0.51
ALOX15 P16050 2/20 0.51
CLK4 Q9HAZ1 2/20 0.51
CYP2C9 P11712 12/20 0.48
CASP7 P55210 7/20 0.47
CYP2D6 P10635 4/20 0.47
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
TSHR P16473 6/20 0.46
HIF1A Q16665 4/20 0.46
HPGD P15428 2/20 0.46
USP2 O75604 7/20 0.45
MAPK1 P28482 2/20 0.45
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7947917 0.89 PDE4B (0.51) CYP1A2ALDH1A1CYP3A4HSD17B10CASP1
SCHEMBL7946067 0.87 PDE4B (0.57) CYP1A2ALDH1A1CYP3A4HSD17B10CASP1
SCHEMBL7944623 0.86 ALDH1A1 (0.66) CYP1A2ALDH1A1CYP3A4HSD17B10CASP1
SCHEMBL7947571 0.86 PDE4B (0.47) PDE4B
SCHEMBL7938164 0.82 PDE4B (0.42) CLK4PDE4B
SCHEMBL7945962 0.81 CYP1A2 (0.59) CYP1A2ALDH1A1CYP3A4HSD17B10CASP1
SCHEMBL7944647 0.78 MTOR (0.53) KMT2APDE4B
SCHEMBL7947184 0.77 CYP1A2 (0.45) CYP1A2ALDH1A1CYP3A4HSD17B10CASP1
SCHEMBL7938416 0.77 CYP1A2 (0.50) CYP1A2ALDH1A1CYP3A4HSD17B10CASP1
SCHEMBL7946753 0.75 ALDH1A1 (0.52) CYP1A2ALDH1A1CYP3A4HSD17B10CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010008775-A1 AMINOPYRIDOPYRAZINONE DERIVATIVES FOR TREATING NEURODEGENERATIVE DISEASES LIGAND PHARMACEUTICALS INC. (US) 2010-01-21 WO disclosed